The clinical effectiveness and safety of low/moderate-intensity statins & ezetimibe combination therapy vs. high-intensity statin monotherapy: a systematic review and meta-analysis

Abstract Background Despite widespread use of high-intensity statin monotherapy, achieving target LDL-C levels and reducing cardiovascular events in patients with or at high risk of developing ASCVD remains challenging. Our study measured the effects of low/moderate-intensity statins and ezetimibe c...

Cijeli opis

Bibliografski detalji

Glavni autori:	Pishoy Sydhom, Bakr Al-Quraishi, Mohamad El-Shawaf, Mohamed T. Osman, Nourhan Naji, Nouran Awwad, Nahla Shehata, Mostafa Osama, Heba Sergany, Kerollos F. Maurice, Ahmed Sayed
Format:	Artigo
Jezik:	Inglês
Izdano:	BMC 2024-11-01
Serija:	BMC Cardiovascular Disorders
Teme:	Statins Ezetimibe Cardiovascular events Coronary artery disease LDL-C
Online pristup:	https://doi.org/10.1186/s12872-024-04144-y
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!